Bio-Works Technologies
4.07 SEK
-4.01 %
Less than 1K followers
BIOWKS
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-4.01 %
+27.19 %
+30.03 %
+55.34 %
+56.54 %
+175.00 %
-65.08 %
-66.11 %
-52.63 %
Bio-Works Technologies operates in biotechnology. The company develops products that separate and purify molecules in the production of pharmaceuticals. The technology is based on chromatography, which is intended to handle the drug substance. Customers are found in the European market where the products are sold via distribution partners and to companies in the pharmaceutical industry, as well as research institutes and universities. The company was founded in 2006 and has its headquarters in Uppsala.
Read moreMarket cap
407.04M SEK
Turnover
373.62K SEK
Revenue
62.5M
EBIT %
-28.03 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
4/6
2026
General meeting '26
21/8
2026
Interim report Q2'26
6/11
2026
Interim report Q3'26
All
Press releases
3rd party
ShowingAll content types
Bio-Works Technologies AB: Bio-Works rapporterar första kvartalet 2026
Bio-Works Technologies AB: Bio-Works receives order for WorkBeads 40S from contract manufacturer in Europe
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools